Tofacitinib . citrate

Overview
Catalog #	bs-75613c-5mg
Product Name	Tofacitinib . citrate
Specifications
Storage Buffer	Solid
Storage Condition	Stable for 2 years after receipt when stored at -20°C.
Target
Product Information	CAS Number: 540737-29-9 Molecular formula: C16H20N6O . C6H8O7 Molecular weight: 312.4 . 192.1 Purity: >98% (HPLC) Appearance: White to off-white solid. Solubility: Soluble in DMSO (20mg/ml) or DMF (5mg/ml). Slightly soluble in ethanol or water. InChiKey: SYIKUFDOYJFGBQ-YLAFAASESA-N SMILES: OC(CC(O)=O)(CC(O)=O)C(O)=O.O=C(CC#N)N1C[C@@H]([C@H](C)CC1)N(C)C2=NC=NC3=C2C=CN3
Description	Potent cell permeable JAK3 inhibitor (IC50 = 1nM). Shows also JAK-1 inhibitory activity. Immunosuppressive and anti-inflammatory agent. Inhibits signaling through heterodimeric receptors associated with JAK3, JAK1, or both of them, with functional selectivity over JAK2-paired receptors. Blocks downstream STAT signaling, resulting in potent inhibition of several cytokines, including interleukins 2, 4, 7, 9, 15 and 21, which are integral to lymphocyte activation, function and proliferation. Investigated for several autoimmune disorders including, rheumatoid arthritis and psoriasis. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19). PRK1 inhibitor.